159 related articles for article (PubMed ID: 32868389)
21. Disease activity in chronic inflammatory demyelinating polyneuropathy.
Albulaihe H; Alabdali M; Alsulaiman A; Abraham A; Breiner A; Barnett C; Katzberg HD; Lovblom LE; Perkins BA; Bril V
J Neurol Sci; 2016 Oct; 369():204-209. PubMed ID: 27653889
[TBL] [Abstract][Full Text] [Related]
22. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands.
Broers MC; de Wilde M; Lingsma HF; van der Lei J; Verhamme KMC; Jacobs BC
J Peripher Nerv Syst; 2022 Sep; 27(3):182-188. PubMed ID: 35567759
[TBL] [Abstract][Full Text] [Related]
24. Fatigue in chronic inflammatory demyelinating polyneuropathy.
Gable KL; Attarian H; Allen JA
Muscle Nerve; 2020 Dec; 62(6):673-680. PubMed ID: 32710648
[TBL] [Abstract][Full Text] [Related]
25. Demyelinating findings in typical and atypical chronic inflammatory demyelinating polyneuropathy: sensitivity and specificity.
De Sousa EA; Chin RL; Sander HW; Latov N; Brannagan TH
J Clin Neuromuscul Dis; 2009 Jun; 10(4):163-9. PubMed ID: 19494726
[TBL] [Abstract][Full Text] [Related]
26. Demyelinating neuropathy in diabetes mellitus.
Sharma KR; Cross J; Farronay O; Ayyar DR; Shebert RT; Bradley WG
Arch Neurol; 2002 May; 59(5):758-65. PubMed ID: 12020257
[TBL] [Abstract][Full Text] [Related]
27. Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy.
Nasu S; Misawa S; Sekiguchi Y; Shibuya K; Kanai K; Fujimaki Y; Ohmori S; Mitsuma S; Koga S; Kuwabara S
J Neurol Neurosurg Psychiatry; 2012 May; 83(5):476-9. PubMed ID: 22338030
[TBL] [Abstract][Full Text] [Related]
28. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
Mygland A; Monstad P
Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
[TBL] [Abstract][Full Text] [Related]
29. Analysis of anti-ganglioside antibodies by a line immunoassay in patients with chronic-inflammatory demyelinating polyneuropathies (CIDP).
Klehmet J; Märschenz S; Ruprecht K; Wunderlich B; Büttner T; Hiemann R; Roggenbuck D; Meisel A
Clin Chem Lab Med; 2018 May; 56(6):919-926. PubMed ID: 29329103
[TBL] [Abstract][Full Text] [Related]
30. Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP.
Abraham A; Breiner A; Katzberg HD; Lovblom LE; Perkins BA; Bril V
Expert Rev Clin Immunol; 2015 Apr; 11(4):537-46. PubMed ID: 25764107
[TBL] [Abstract][Full Text] [Related]
31. Does the chronic inflammatory demyelinating polyradiculoneuropathy due to secondary cause differ from primary?
Wadwekar V; Kalita J; Misra UK
Neurol India; 2011; 59(5):664-8. PubMed ID: 22019647
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment response in the asymmetric variant of chronic inflammatory demyelinating polyneuropathy.
Lucke IM; Wieske L; van der Kooi AJ; van Schaik IN; Eftimov F; Verhamme C
J Peripher Nerv Syst; 2019 Jun; 24(2):174-179. PubMed ID: 31090121
[TBL] [Abstract][Full Text] [Related]
33. Prospective study of the additional benefit of plexus magnetic resonance imaging in the diagnosis of chronic inflammatory demyelinating polyneuropathy.
Jomier F; Bousson V; Viala K; Péréon Y; Magot A; Cauquil C; Bouhour F; Vial C; Bedat-Millet AL; Taithe F; Bresch S; Siri A; Kubis N; Lozeron P
Eur J Neurol; 2020 Jan; 27(1):181-187. PubMed ID: 31348848
[TBL] [Abstract][Full Text] [Related]
34. CIDP and other inflammatory neuropathies in diabetes - diagnosis and management.
Rajabally YA; Stettner M; Kieseier BC; Hartung HP; Malik RA
Nat Rev Neurol; 2017 Oct; 13(10):599-611. PubMed ID: 28914883
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 2-limb versus 3-limb electrodiagnostic studies in the evaluation of chronic inflammatory demyelinating polyneuropathy.
Vo ML; Hanineva A; Chin RL; Carey BT; Latov N; Langsdorf JA
Muscle Nerve; 2015 Apr; 51(4):549-53. PubMed ID: 25131219
[TBL] [Abstract][Full Text] [Related]
36. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
Kalita J; Misra UK; Yadav RK
Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
[TBL] [Abstract][Full Text] [Related]
37. Chronic Inflammatory Demyelinating Polyneuropathy.
Kuwabara S; Misawa S
Adv Exp Med Biol; 2019; 1190():333-343. PubMed ID: 31760654
[TBL] [Abstract][Full Text] [Related]
38. Elevated serum levels of endothelin-1 in patients with chronic inflammatory demyelinating polyneuropathy.
Chang CW; Wu HC; Lyu RK; Lo YS; Chen CM; Ro LS; Chang HS; Huang CC; Liao MF; Wu YR; Kuo HC; Chu CC; Weng YC; Wei PT; Lo AL; Chang KH
Clin Chim Acta; 2018 Jan; 476():49-53. PubMed ID: 29137897
[TBL] [Abstract][Full Text] [Related]
39. Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.
Lawley A; Seri S; Rajabally YA
Clin Neurophysiol; 2019 Oct; 130(10):1743-1749. PubMed ID: 31400577
[TBL] [Abstract][Full Text] [Related]
40. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
Echaniz-Laguna A; de Séze J; Chanson JB
J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]